Login / Signup

Discovery reliability.

Anders Hånell
Published in: Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism (2019)
Whenever an experiment yields a statistically significant outcome you should ask yourself: To what extent can I trust this result? This is especially important for pre-clinical drug studies because of the frequent failures of phase III clinical trials of neurological diseases, which has put the reliability of pre-clinical research into question. Two important factors, the pre-study likelihood of treatment benefit, and statistical power, affects the reliability of the result in a quantifiable way. This can be used to assess to what extent the result of a study can be trusted (discovery reliability), and to guide the design of pre-clinical research.
Keyphrases
  • clinical trial
  • phase iii
  • small molecule
  • open label
  • high throughput
  • randomized controlled trial
  • emergency department
  • healthcare
  • health information
  • combination therapy
  • blood brain barrier
  • brain injury
  • adverse drug